The stock options have an exercise price of
About
Company Contact:
Director, Head of Corporate Communications and Investor Relations
hcollins@tayshagtx.com
Media Contact:
carolyn.hawley@canalecomm.com
![](https://ml.globenewswire.com/media/OGNjYjczNmMtOTZjNy00YWZkLTkxODUtYWIzNDE2ZTE5NDU4LTUwMDEwMzIzNw==/tiny/Taysha-Gene-Therapies-Inc-.png)
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 USD | -4.80% |
|
+0.51% | +124.29% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
The stock options have an exercise price of
About
Company Contact:
Director, Head of Corporate Communications and Investor Relations
hcollins@tayshagtx.com
Media Contact:
carolyn.hawley@canalecomm.com
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+124.29% | 742M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |